Cambridge, MA, United States of America

Angela Early

This inventor holds 1 USPTO granted patent. Top assignees: Harvard College, Massachusetts Institute of Technology, The Broad Institute, Inc.. Active years: 2023.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angela Early: Innovator in CRISPR-Based Diagnostics

Introduction

Angela Early is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of diagnostics, particularly through her innovative work with CRISPR technology. Her research focuses on developing advanced diagnostic tools that can enhance disease detection and improve health outcomes.

Latest Patents

Angela Early holds a patent for a CRISPR effector system-based diagnostic for malaria detection. The embodiments disclosed in her patent utilize RNA targeting effectors to provide a robust CRISPR-based diagnostic with attomolar sensitivity. This technology can detect both DNA and RNA with comparable levels of sensitivity and can differentiate targets from non-targets based on single base pair differences. Additionally, the embodiments can be prepared in a freeze-dried format for convenient distribution and point-of-care (POC) applications. Such innovations are valuable in various human health scenarios, including viral detection, bacterial strain typing, sensitive genotyping, and the detection of disease-associated cell-free DNA.

Career Highlights

Angela has worked with esteemed organizations such as the Broad Institute, Inc. and Harvard College. Her experience in these institutions has allowed her to collaborate with leading scientists and contribute to groundbreaking research in the field of molecular biology and diagnostics.

Collaborations

Some of her notable coworkers include James Joseph Collins and Jonathan S. Gootenberg. Their collaborative efforts have further advanced the applications of CRISPR technology in diagnostics and therapeutics.

Conclusion

Angela Early is a trailblazer in the field of CRISPR-based diagnostics, with her innovative patent paving the way for improved disease detection methods. Her work exemplifies the potential of scientific research to transform healthcare and enhance patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…